

        Unlikely to survive after 48 hours from screening or unlikely to remain at the
        investigational site beyond 48 hours Presence of neutropenia less than 2000/mm3, aspartate
        aminotransferase (AST) or ALT greater than 5 X ULN, platelets less than 50,000/mm3 Prior
        immunosuppressive therapies Use of chronic oral corticosteroids for non-COVID-19 related
        condition Known or suspected history of tuberculosis Suspected or known active systemic
        bacterial or fungal infections

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.
      